Members of the newly established NORML at the University of Utah hosted a panel discussion to explore the current state of marijuana law reform efforts in Utah, which included Proposition 2, as well as the negative impacts marijuana prohibition has had on Utahns.
Category: Medical Marijuana
The marijuana midterms are fast approaching. If you live in any of these 16 counties and/or two cities, be sure to vote YES on the following marijuana ballot questions.
One of NORML’s primary missions is to move public opinion sufficiently to legalize the responsible use of marijuana by adults. One of the ways we successfully achieve this goal is by authoring and routinely placing op-eds in high-profile, mainstream newspapers and media outlets.
The use of cannabis is relatively common among those over the age of 65 who reside in a legal marijuana state, according to data published online in the Journal of the American Geriatrics Society. Authors concluded, “Respondents reported using recreational marijuana to target a variety of medical symptoms and conditions with few reported adverse effects.”
Epidiolex, a prescription medicine containing a standardized formulation of plant-derived cannabidiol (CBD), has been reclassified today by the US Drug Enforcement Administration to Schedule V — the lowest restriction classification available under federal law. The rescheduling change is only specific to Epidiolex, and does not amend the schedule I status of either whole-plant cannabis of CBD.
Lawmakers have removed language from pending federal legislation that sought to facilitate veterans’ access to medical cannabis in jurisdictions that regulate it.
Senators Brian Schatz (D-HI) and Bill Nelson (D-FL) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act, to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.